← Leaderboards
Oleg Alekseev
Drexel University
$873,076
Attributed
$873,076
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $170.7K · FY2012–25$200K$150K$100K$50K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$873,076 · 2
By mechanism
K08$682,816 · 1
F30$190,260 · 1
Top collaborators
No co-investigators on record.
Most similar at Drexel University
Same institution · by research overlap
- Christine M Finck$4,232,950
- Jasmine Peake$89,043
Others in their field
Top investigators on “Pathology”
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Paul S. Aisen · Cognition Therapeutics, Inc.$155,099,919
- Reisa A. Sperling · Banner Health$154,825,070
- Ronald T Mitsuyasu · University Of California Los Angeles$145,092,412
- Joseph E Robertson · Oregon Health & Science University$126,125,279
Research focus
PathologyStressSmall MoleculeResponseAffectInvestigationMolecularSiteCellular TargetingEquilibriumBindingAmericanBinding SitesBlindnessEnhancersEtiologyDrug KineticsCellular StressDisease-Causing MutationDrug TargetingDosageDrug EvaluationCiliopathyCellular Pathology
Grant awards (8)
Role of Proteasome Overload in Pathogenesis of Retinitis Pigmentosa$170,704
K08 · FY2025 · EY · contact PI
Role of Proteasome Overload in Pathogenesis of Retinitis Pigmentosa$170,704
K08 · FY2024 · EY · contact PI
Role of Proteasome Overload in Pathogenesis of Retinitis Pigmentosa$170,704
K08 · FY2023 · EY · contact PI
Role of Proteasome Overload in Pathogenesis of Retinitis Pigmentosa$170,704
K08 · FY2022 · EY · contact PI
Targeting the DNA damage response pathway for the treatment of HSV esophagitis$48,120
F30 · FY2015 · DK · contact PI
Targeting the DNA damage response pathway for the treatment of HSV esophagitis$47,676
F30 · FY2014 · DK · contact PI
Targeting the DNA damage response pathway for the treatment of HSV esophagitis$47,232
F30 · FY2013 · DK · contact PI
Targeting the DNA damage response pathway for the treatment of HSV esophagitis$47,232
F30 · FY2012 · DK · contact PI